Moreover, stromal IGF2 induces NANOG expression and thus boosts the cancer-initiating properties of lung cancer cells through IR/IGF1R signaling followed by activation of the AKT-PI3K pathway [88]. The gene discussed is AKT1; the disease is lung carcinoma.